CHRNA5/CHRNA3 Locus Associates with Increased Mortality among Smokers

References

• Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000; 343(4):269–280.
   Google Scholar
• Benowitz NL. Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Prog Cardiovasc Dis 2003; 46(1):91–111.
   Google Scholar
• Lee PN, Forey BA, Coombs KJ. Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer. BMC Cancer 2012; 12:385,2407-12-385.
   Google Scholar
• Tobacco and Genetics Consortium. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet 2010; 42(5):441–447.
   Google Scholar
• Siedlinski M, Cho MH, Bakke P, Gulsvik A, Lomas DA, Anderson W, et al. Genome-wide association study of smoking behaviours in patients with COPD. Thorax 2011; 66(10):894–902.
   Google Scholar
• Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008; 452(7187):638–642.
   Google Scholar
• The HapMap project [Internet]. Available from: http://hapmap.ncbi.nlm.nih.gov/ ( accessed 2 February, 2015 ).
   Google Scholar
• Munafo MR, Timofeeva MN, Morris RW, Prieto-Merino D, Sattar N, Brennan P, et al. Association between genetic variants on chromosome 15q25 locus and objective measures of tobacco exposure. J Natl Cancer Inst 2012; 104(10):740–748.
   Google Scholar
• Saccone SF, Hinrichs AL, Saccone NL, Chase GA, Konvicka K, Madden PA, et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet. 2007; 16(1):36–49.
   PubMed Web of Science ®Google Scholar
• Ware JJ, van den Bree MB, Munafo MR. Association of the CHRNA5-A3-B4 gene cluster with heaviness of smoking: a meta-analysis. Nicotine Tob Res 2011; 13(12):1167–1175.
   Google Scholar
• Gu M, Dong X, Zhang X, Wang X, Qi Y, Yu J, et al. Strong association between two polymorphisms on 15q25.1 and lung cancer risk: a meta-analysis. PLoS One 2012; 7(6):e37970.
   Google Scholar
• Liu P, Vikis HG, Wang D, Lu Y, Wang Y, Schwartz AG, et al. Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. J Natl Cancer Inst 2008; 100(18):1326–1330.
   Google Scholar
• Sakoda LC, Loomis MM, Doherty JA, Neuhouser ML, Barnett MJ, Thornquist MD, et al. Chromosome 15q24-25.1 variants, diet, and lung cancer susceptibility in cigarette smokers. Cancer Causes Control 2011; 22(3):449–461.
   Google Scholar
• Kaur-Knudsen D, Nordestgaard BG, Bojesen SE. CHRNA3 genotype, nicotine dependence, lung function and disease in the general population. Eur Respir J 2012; 40(6):1538–1544.
   Google Scholar
• Lambrechts D, Buysschaert I, Zanen P, Coolen J, Lays N, Cuppens H, et al. The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysema. Am J Respir Crit Care Med 2010; 181(5):486–493.
   Google Scholar
• Pillai SG, Ge D, Zhu G, Kong X, Shianna KV, Need AC, et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 2009; 5(3):e1000421.
   Google Scholar
• Freathy RM, Ring SM, Shields B, Galobardes B, Knight B, Weedon MN, et al. A common genetic variant in the 15q24 nicotinic acetylcholine receptor gene cluster (CHRNA5-CHRNA3-CHRNB4) is associated with a reduced ability of women to quit smoking in pregnancy. Hum Mol Genet 2009; 18(15):2922–2927.
   Google Scholar
• Thorgeirsson TE, Stefansson K. Commentary: gene-environment interactions and smoking-related cancers. Int J Epidemiol 2010; 39(2):577–579.
   Google Scholar
• Mohamed Hoesein FA, Wauters E, Janssens W, Groen HJ, Smolonska J, Wijmenga C, et al. Variants in the 15q24/25 locus associate with lung function decline in active smokers. PLoS One 2013; 8(1):e53219.
   Google Scholar
• Hong LE, Yang X, Wonodi I, Hodgkinson CA, Goldman D, Stine OC, et al. A CHRNA5 allele related to nicotine addiction and schizophrenia. Genes Brain Behav 2011; 10(5):530–535.
   Google Scholar
• Wang JC, Grucza R, Cruchaga C, Hinrichs AL, Bertelsen S, Budde JP, et al. Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence. Mol Psych 2009; 14(5):501–510.
   Google Scholar
• Winterer G, Mittelstrass K, Giegling I, Lamina C, Fehr C, Brenner H, et al. Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance. Am J Med Genet B Neuropsychiatr Genet 2010; 153B(8):1448–1458.
   PubMed Web of Science ®Google Scholar
• Etter JF, Hoda JC, Perroud N, Munafo M, Buresi C, Duret C, et al. Association of genes coding for the alpha-4, alpha-5, beta-2 and beta-3 subunits of nicotinic receptors with cigarette smoking and nicotine dependence. Addict Behav 2009; 34(9):772–775.
   Google Scholar
• Laitinen T, Hodgson U, Kupiainen H, Tammilehto L, Haahtela T, Kilpelainen M, et al. Real-world clinical data identifies gender-related profiles in chronic obstructive pulmonary disease. COPD 2009; 6(4):256–262.
   Google Scholar
• Kupiainen H, Kinnula VL, Lindqvist A, Postma DS, Boezen HM, Laitinen T, et al. Successful smoking cessation in COPD: Association with comorbidities and mortality. Pulm Med 2012; 2012:725024.
   Google Scholar
• Health and functional capacity in Finland Baseline results of the Health2000 examination survey [Internet]: National Institute of Health and Welfare 2004. Available from: www.terveys2000.fi/julkaisut/baseline.pdf (accessed 20 January, 2015).
   Google Scholar
• The ATBC Cancer Prevention Study Group. The Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study: design, methods, participant characteristics and compliance.. 1994;4(Ann Epidemiol):1–10.
   Google Scholar
• Salaspuro M, Kiianmaa K, Seppä K. Alkoholiongelman varhaistoteaminen. In: Seppä K, editor. Päihdelääketiede. Helsinki, Finland: Kustannus Oy Duodecim; 2003; 58.
   Google Scholar
• Evans A, Salomaa V, Kulathinal S, Asplund K, Cambien F, Ferrario M, et al. MORGAM (an international pooling of cardiovascular cohorts). Int J Epidemiol 2005; 34(1):21–27.
   Google Scholar
• Wilk JB, Shrine NR, Loehr LR, Zhao JH, Manichaikul A, Lopez LM, et al. Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. Am J Respir Crit Care Med 2012; 186(7):622–632.
   Google Scholar
• Statistics Finland [Internet]. 2012. Available from: http://www.stat.fi/til/vaenn/2012/vaenn_2012_2012-09-28_tau_001_fi.html( accessed 15 February, 2015).
   Google Scholar
• Soto-Campos JG, Plaza V, Soriano JB, Cabrera-Lopez C, Almonacid-Sanchez C, Vazquezoliva RM, et al. Causes of death in asthma, COPD and non-respiratory hospitalized patients: a multicentric study. BMC Pulm Med 2013; 13(1):73.
   Google Scholar
• McGarvey LP, Magder S, Burkhart D, Kesten S, Liu D, Manuel RC, et al. Cause-specific mortality adjudication in the UPLIFT(R) COPD trial: findings and recommendations. Respir Med 2012; 106(4):515–521.
   Google Scholar
• Budulac SE, Vonk JM, Postma DS, Siedlinski M, Timens W, Boezen MH. Nicotinic acetylcholine receptor variants are related to smoking habits, but not directly to COPD. PLoS One 2012; 7(3):e33386.
   Google Scholar
• Ware JJ, van den Bree M, Munafo MR. From men to mice: CHRNA5/CHRNA3, smoking behavior and disease. Nicotine Tob Res 2012; 14(11):1291–1299.
   Google Scholar
• Siedlinski M, Tingley D, Lipman PJ, Cho MH, Litonjua AA, Sparrow D, et al. Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility. Hum Genet. 2013 Apr;132(4):431–41.
   PubMed Web of Science ®Google Scholar
• Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008; 452(7187):633–637.
   Google Scholar
• Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008; 40(5):616–622.
   Google Scholar
• Kaur-Knudsen D, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. Nicotinic acetylcholine receptor polymorphism, smoking behavior, and tobacco-related cancer and lung and cardiovascular diseases: a cohort study. J Clin Oncol 2011; 29(21):2875–2882.
   Google Scholar
• VanderWeele TJ, Asomaning K, Tchetgen Tchetgen EJ, Han Y, Spitz MR, Shete S, et al. Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction. Am J Epidemiol 2012; 175(10):1013–1020.
   Google Scholar
• Wang Y, Broderick P, Matakidou A, Eisen T, Houlston RS. Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers. Carcinogenesis 2010; 31(2):234–238.
   Google Scholar
• Truong T, Hung RJ, Amos CI, Wu X, Bickeboller H, Rosenberger A, et al. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst 2010; 102(13):959–971.
   Google Scholar
• Keskitalo K, Broms U, Heliovaara M, Ripatti S, Surakka I, Perola M, et al. Association of serum cotinine level with a cluster of three nicotinic acetylcholine receptor genes (CHRNA3/CHRNA5/CHRNB4) on chromosome 15. Hum Mol Genet 2009; 18(20):4007–4012.
   Google Scholar
• Shipton D, Tappin DM, Vadiveloo T, Crossley JA, Aitken DA, Chalmers J. Reliability of self reported smoking status by pregnant women for estimating smoking prevalence: a retrospective, cross sectional study. Br Med J 2009; 339:b4347.
   Google Scholar